Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Autres titres de la collection: Chapman & Hall/CRC Biostatistics Series
Afficher toutMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
disponible de suite
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
env. 140.00 CHF
livrable dans env. 10-20 jours
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
env. 80.00 CHF
livrable dans env. 10-20 jours
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
env. 86.00 CHF
livrable dans env. 10-20 jours
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
env. 146.00 CHF
livrable dans env. 10-20 jours
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
env. 156.00 CHF
livrable dans env. 10-20 jours
Autres titres sur ce thème
Topical Dermal Drug Delivery
Concepts and Advances
Elsevier, 2026
978-0-443-21945-0
env. 215.00 CHF
paraît en octobre
Nanoengineered Therapeutics for Lung Cancer
Advanced Drug Delivery Strategies
978-0-443-44585-9
env. 235.00 CHF
paraît en octobre
Cellular Therapies for Cancer Treatment
Advancements in Drug Delivery Strategies
Elsevier, 2026
978-0-443-34141-0
env. 229.00 CHF
paraît en octobre
Mastering the Medical Science Liaison Career Path
The Science of Influence
Taylor and Francis, 2026
978-1-041-31966-5
env. 95.00 CHF
livrable dans env. 10-20 jours
Bayesian Entrepreneurship
University Presses, 2026
978-0-262-05215-3
env. 185.00 CHF
livrable dans env. 20-45 jours
Multi-Criteria Decision-Making
Principles, Methods and Programs
Taylor and Francis, 2026
978-1-032-85363-5
env. 160.00 CHF
livrable dans env. 10-20 jours
Derivatives
Mathematical Foundations for Finance Students
Taylor and Francis, 2026
978-1-032-76219-7
env. 209.00 CHF
paraît en juin
Dynamic Programming for Economists
From Basic Growth Models to Computational Methods
Taylor and Francis, 2026
978-1-041-30339-8
env. 85.00 CHF
paraît en juillet
Process Analytical Technology and Data Analysis for the Manufacturing of ...
Taylor and Francis, 2026
978-1-032-66291-6
env. 169.00 CHF
paraît en août
Dust Explosions in the Pharmaceutical and Food Industries
Taylor and Francis, 2026
978-1-041-08425-9
env. 209.00 CHF
paraît en août
Mitochondria-targeted Drug Delivery Strategies for Cancer Therapy
Elsevier, 2026
978-0-443-40479-5
env. 275.00 CHF
paraît en juillet
AI Powered Drug delivery to Neuro and Cardiovascular Systems
Perspectives and Future Challenges
Elsevier, 2026
978-0-443-40441-2
env. 225.00 CHF
livrable dans env. 10-20 jours

